Phoenix Wealth Advisors Edwards Lifesciences Corp Transaction History

Phoenix Wealth Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$106.37 - $130.68 $19,146 - $23,522	-180 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $18,523 - $22,095	-180 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$83.84 - $104.76 $15,091 - $18,856	180 New	180 $19,000
Q1 2021 Apr 12, 2021	SELL	$78.68 - $90.67 $14,162 - $16,320	-180 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$71.69 - $91.23 $12,904 - $16,421	180 New	180 $16,000

1,349

456M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Phoenix Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Phoenix Wealth Advisors with notifications on news.